On December 1st, Anvisa published the eighth health authorization for a cannabis-based product.
It is an oral solution under the name Cannabidiol Verdemed 23.75 mg/mL.
The product can be sold in pharmacies and drugstores from a medical prescription through a type B prescription (blue).
The product is manufactured in Colombia.
At the end of 2019, Anvisa authorized the sale of cannabis-based products in pharmacies, provided that the substrate or the entire product is imported. Marijuana cultivation remains prohibited.
Source: O Antagonista
